Citrate Pharmacokinetics in Critically Ill Patients with Acute Kidney Injury

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zheng, Yin ^a   Xu, Zhongye ^a   Zhu, Qiuyu ^a   Liu, Junfeng ^a   Qian, Jing ^a   You, Huaizhou ^a   Gu, Yong ^a   Hao, Chuanming ^a   Jiao, Zheng ^a   Ding, Feng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; CITRATE TRISODIUM; ANTICOAGULANT AGENT; CITRIC ACID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG INFUSION; DRUG SUBSTITUTION; FEMALE; HUMAN; LIVER DYSFUNCTION; MALE; MAXIMUM PLASMA CONCENTRATION; POPULATION RESEARCH; RISK ASSESSMENT; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION STUDY; VOLUNTEER; ADOLESCENT; CRITICAL ILLNESS; HEMOFILTRATION; METABOLISM; MIDDLE AGED;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; CITRIC ACID; CRITICAL ILLNESS; FEMALE; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED;

EID: 84879164161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065992     Document Type: Article

References (21)

1. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J, (2005) Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 67: 2361-2367.
2. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, et al. (2012) Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-anlysis of randomized controlled trails. Am J Kidney Dis 59 (6): 810-818.
3. Durao MS, Monte JC, Batista MC, Oliveira M, Iizuka IJ, et al. (2008) The use of regional citrate anticoagulation for continous venovenous hemodiafiltration in acute kidney injury. Crit Care Med 36: 3024-3029.
4. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, et al. (1999) Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 56: 1578-1583.
5. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T, (2005) Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 20: 155-161.
6. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, et al. (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30: 260-265.
7. Dhondt A, Vanholder R, Tielemans C, Glorieux G, Waterloos MA, et al. (2000) Effect of regional citrate anti-coagulation on leucopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes. Nephron 85: 334-342.
8. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JI, et al. (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37: 545-552.
9. Wexler IB, Pincus JB, Natelson S, (2009) The fate of citrate in erythroblastic infants treated with exchange transfusion. J Clin Invest 28: 474-481.
10. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, et al. (2003) Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 31: 2450-2455.
11. Bauer E, Derfler K, Joukhadar C, Druml W, (2005) Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis 46: 903-907.
12. Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, et al. (2009) A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 37: 2018-2024.
13. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T, (2001) Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29: 748-752.
14. Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, et al. (2011) Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant 26(12): 3882-3888.
15. Whitfield LR, Levy G, (1981) Permeability of human and rat red blood cells to citrate. Thromb Res 21: 681-684.
16. Yee J, Frinak S, Szamosfalvi B, (2007) Comprehensive citrate kinetic analysis: An indispensable tool for the design of safe regional citrate anticoagulation protocols [Abstract] J Am Soc Nephrol. 18: 455A.
17. Bohler J, Donauer J, Keller F (1999) Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage. Kidney Int Suppl 72: S24-S28.
18. Chow Shein-Chung, Hansheng Wang, Jun Shao (2003) Sample Size Calculations in Clinical Research. 56 p.
19. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, et al. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710.
20. Apsner R, Schwarzenhofer M, Derfler K, Zauner C, Ratheiser K, et al. (1997) Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 109: 123-127.
21. Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Böhler J, (2009) Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant 24(7): 2244-2251.